These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Pancreatic metastasis from a Merkel cell carcinoma diagnosed by ultrasound-guided biopsy]. García García de Paredes A; Tavío Hernández E; Foruny Olcina JR; Montans Araujo J; Boixeda de Miquel D; Albillos Martínez A Gastroenterol Hepatol; 2016; 39(6):395-7. PubMed ID: 26183234 [No Abstract] [Full Text] [Related]
28. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer. Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B; Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946 [TBL] [Abstract][Full Text] [Related]
29. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery]. Kunitomo K; Kawahito M; Miura M; Komi N Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863 [No Abstract] [Full Text] [Related]
30. Current status of chemotherapy in metastatic pancreatic cancer. Wils JA Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988 [TBL] [Abstract][Full Text] [Related]
31. [Effect of combination chemotherapy of low-dose CDDP. Continuous infusion of 5-FU, and intermittent CPT-11 administration for 2 advanced pancreatic cancer cases with liver metastasis]. Kobayashi A; Yamaguchi M Gan To Kagaku Ryoho; 1998 Sep; 25(11):1755-9. PubMed ID: 9757202 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma. Bekaii-Saab T; Yu K; Lima CMSR; Wolin EM Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):1-16. PubMed ID: 30807558 [No Abstract] [Full Text] [Related]
34. [Combined palliative subtotal pancreatectomy with resection of two hollow organs in cancer surgery]. Basheev VKh; Ladur AI; Donets VL; Bogdanov VA Klin Khir; 2001 Apr; (4):57-8. PubMed ID: 11482200 [No Abstract] [Full Text] [Related]
35. Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient. Berger AK; Haag GM; Ehmann M; Byl A; Jäger D; Springfeld C BMC Gastroenterol; 2017 Dec; 17(1):143. PubMed ID: 29207968 [TBL] [Abstract][Full Text] [Related]
36. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma. Lima CMSR Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559 [No Abstract] [Full Text] [Related]
37. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When? Kim MP; Katz MHG Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479 [No Abstract] [Full Text] [Related]
39. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer. Khan M; Ashraf MI; Syed AA; Hanif F J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837 [TBL] [Abstract][Full Text] [Related]
40. Unresectable adenocarcinoma of the pancreas. Klaassen DJ Cancer Invest; 2000; 18(4):406-7. PubMed ID: 10808378 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]